Blueprint Medicines Corp’s filing revealed that its CHIEF OPERATING OFFICER Rossi Christina unloaded Company’s shares for reported $0.22 million on Nov 27 ’24. In the deal valued at $95.10 per share,2,274 shares were sold. As a result of this transaction, Rossi Christina now holds 71,657 shares worth roughly $7.0 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, KATHRYN D HAVILAND bought 3,799 shares, generating $361,285 in total proceeds.
Before that, Christina Rossi and Gregory Pa bought 9,096 shares. Blueprint Medicines Corp shares valued at $860,754 were divested by the Affiliate at a price of $94.63 per share.
JP Morgan initiated its Blueprint Medicines Corp [BPMC] rating to an Overweight in a research note published on November 14, 2024; the price target was $126. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Neutral”‘ rating. Stephens began covering BPMC with “an Overweight” recommendation on May 14, 2024. Leerink Partners revised its rating on May 06, 2024. It rated BPMC as “a Market perform” which previously was an “an Underperform”.
Price Performance Review of BPMC
On Monday, Blueprint Medicines Corp [NASDAQ:BPMC] saw its stock jump 1.29% to $97.62. Over the last five days, the stock has gained 3.69%. Blueprint Medicines Corp shares have risen nearly 5.83% since the year began. Nevertheless, the stocks have risen 40.18% over the past one year. While a 52-week high of $121.90 was reached on 07/16/24, a 52-week low of $68.28 was recorded on 02/14/24. SMA at 50 days reached $91.02, while 200 days put it at $96.53.
Levels Of Support And Resistance For BPMC Stock
The 24-hour chart illustrates a support level at 96.25, which if violated will result in even more drops to 94.87. On the upside, there is a resistance level at 98.50. A further resistance level may holdings at 99.37. The Relative Strength Index (RSI) on the 14-day chart is 58.90, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.67, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 25.23%. Stochastics %K at 58.00% indicates the stock is a holding.
How much short interest is there in Blueprint Medicines Corp?
A steep rise in short interest was recorded in Blueprint Medicines Corp stocks on 2024-11-15, growing by 0.29 million shares to a total of 3.91 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 3.62 million shares. There was a rise of 7.48%, which implies that there is a positive sentiment for the stock.
